Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

HPV 16 E7:86-93 peptide vaccine

A synthetic peptide vaccine consisting of amino acids 86 through 93 (TLGIVCPI) of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16 E7:86-93 peptide, which binds to HLA-A* 0201 molecule, may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for HPV-16 E7.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:E7(86-93) lipopeptide
HPV 16E7 86-93 Lipopeptide Vaccine
HPV-16E7 (86-93)
Abbreviation:E7(86-93)
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search